BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 34057990)

  • 1. Outcomes after breast-conserving surgery or mastectomy in patients with triple-negative breast cancer: meta-analysis.
    Fancellu A; Houssami N; Sanna V; Porcu A; Ninniri C; Marinovich ML
    Br J Surg; 2021 Jul; 108(7):760-768. PubMed ID: 34057990
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The different outcomes between breast-conserving surgery and mastectomy in triple-negative breast cancer: a population-based study from the SEER 18 database.
    Chen QX; Wang XX; Lin PY; Zhang J; Li JJ; Song CG; Shao ZM
    Oncotarget; 2017 Jan; 8(3):4773-4780. PubMed ID: 27999201
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Breast conserving surgery (BCS) with adjuvant radiation therapy showed improved prognosis compared with mastectomy for early staged triple negative breast cancer patients Running title: BCS had better prognosis than mastectomy for early TNBC patients.
    Wang SE; Sun YD; Zhao SJ; Wei F; Yang G
    Math Biosci Eng; 2019 Sep; 17(1):92-104. PubMed ID: 31731341
    [No Abstract]   [Full Text] [Related]  

  • 4. Breast-conserving therapy achieves locoregional outcomes comparable to mastectomy in women with T1-2N0 triple-negative breast cancer.
    Zumsteg ZS; Morrow M; Arnold B; Zheng J; Zhang Z; Robson M; Traina T; McCormick B; Powell S; Ho AY
    Ann Surg Oncol; 2013 Oct; 20(11):3469-76. PubMed ID: 23686101
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Breast-conserving surgery is not associated with increased local recurrence in patients with early-stage node-negative triple-negative breast cancer treated with neoadjuvant chemotherapy.
    Krug D; Vladimirova V; Untch M; Kühn T; Schneeweiss A; Denkert C; Ataseven B; Solbach C; Gerber B; Tesch H; Golatta M; Seiler S; Heil J; Nekljudova V; Holtschmidt J; Loibl S
    Breast; 2024 Apr; 74():103701. PubMed ID: 38422624
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Breast Conservation Therapy Versus Mastectomy in Patients with T1-2N1 Triple-Negative Breast Cancer: Pooled Analysis of KROG 14-18 and 14-23.
    Kim K; Park HJ; Shin KH; Kim JH; Choi DH; Park W; Ahn SD; Kim SS; Kim DY; Kim TH; Kim JH; Kim J
    Cancer Res Treat; 2018 Oct; 50(4):1316-1323. PubMed ID: 29334604
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Breast-conserving surgery vs. total mastectomy in patients with triple negative breast cancer in early stages: A propensity score analysis.
    De-la-Cruz-Ku G; Valcarcel B; Morante Z; Möller MG; Lizandro S; Rebaza LP; Enriquez D; Luque R; Luján-Peche MG; Eyzaguirre-Sandoval ME; Saavedra A; Razuri C; Pinto JA; Fuentes HA; Neciosup SP; Gomez HL
    Breast Dis; 2020; 39(1):29-35. PubMed ID: 31903977
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Breast-conserving surgery versus mastectomy for older women with triple-negative breast cancer: population-based study.
    Mburu W; Kulasingam S; Hodges JS; Virnig BA
    J Comp Eff Res; 2022 Sep; 11(13):953-967. PubMed ID: 35894095
    [No Abstract]   [Full Text] [Related]  

  • 9. Oncologic safety of breast-conserving surgery compared to mastectomy in patients receiving neoadjuvant chemotherapy for locally advanced breast cancer.
    Cho JH; Park JM; Park HS; Park S; Kim SI; Park BW
    J Surg Oncol; 2013 Dec; 108(8):531-6. PubMed ID: 24115142
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Black race as a prognostic factor in triple-negative breast cancer patients treated with breast-conserving therapy: a large, single-institution retrospective analysis.
    Perez CA; Zumsteg ZS; Gupta G; Morrow M; Arnold B; Patil SM; Traina TA; Robson ME; Wen YH; McCormick B; Powell SN; Ho AY
    Breast Cancer Res Treat; 2013 Jun; 139(2):497-506. PubMed ID: 23645006
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Locoregional and distant recurrences after breast conserving therapy in patients with triple-negative breast cancer: a meta-analysis.
    Wang J; Xie X; Wang X; Tang J; Pan Q; Zhang Y; Di M
    Surg Oncol; 2013 Dec; 22(4):247-55. PubMed ID: 24144808
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Breast conservation therapy confers survival and distant recurrence advantage over mastectomy for stage II Triple Negative Breast cancer.
    Macfie R; Aks C; Panwala K; Johnson N; Jennifer Garreau
    Am J Surg; 2021 Apr; 221(4):809-812. PubMed ID: 32430151
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Local treatment for triple-negative breast cancer patients undergoing chemotherapy: breast-conserving surgery or total mastectomy?
    Guo L; Xie G; Wang R; Yang L; Sun L; Xu M; Yang W; Chung MC
    BMC Cancer; 2021 Jun; 21(1):717. PubMed ID: 34147061
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of Adjuvant Treatments for T1 N0 M0 Triple-Negative Breast Cancer.
    Zhai Z; Zheng Y; Yao J; Liu Y; Ruan J; Deng Y; Zhou L; Zhao P; Yang S; Hu J; We B; Wu Y; Zhang D; Kang H; Dai Z
    JAMA Netw Open; 2020 Nov; 3(11):e2021881. PubMed ID: 33211105
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Breast-conserving therapy for triple-negative breast cancer.
    Gangi A; Chung A; Mirocha J; Liou DZ; Leong T; Giuliano AE
    JAMA Surg; 2014 Mar; 149(3):252-8. PubMed ID: 24382582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Local Treatment of Triple-Negative Breast Cancer: Is Mastectomy Superior to Breast-Conserving Surgery?
    Di Leone A; Franco A; Zotta F; Scardina L; Sicignano M; Di Guglielmo E; Castagnetta V; Magno S; Terribile D; Sanchez AM; Franceschini G; Masetti R
    J Pers Med; 2023 May; 13(5):. PubMed ID: 37241035
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between initiation of adjuvant chemotherapy beyond 30 days after surgery and overall survival among patients with triple-negative breast cancer.
    Heeg E; Marang-van de Mheen PJ; Van Maaren MC; Schreuder K; Tollenaar RAEM; Siesling S; Bos MEMM; Vrancken Peeters MTFD
    Int J Cancer; 2020 Jul; 147(1):152-159. PubMed ID: 31721193
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Breast-conserving surgery versus mastectomy for treatment of breast cancer after neoadjuvant chemotherapy.
    Song YC; Huang Z; Fang H; Tang Y; Jing H; Song YW; Jin J; Liu YP; Chen B; Tang Y; Qi SN; Lu NN; Li N; Li YX; Wang SL
    Front Oncol; 2023; 13():1178230. PubMed ID: 37496664
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Meta-analysis of neoadjuvant therapy and its impact in facilitating breast conservation in operable breast cancer.
    Karakatsanis A; Tasoulis MK; Wärnberg F; Nilsson G; MacNeill F
    Br J Surg; 2018 Apr; 105(5):469-481. PubMed ID: 29603132
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Triple-negative breast cancer is not a contraindication for breast conservation.
    Adkins FC; Gonzalez-Angulo AM; Lei X; Hernandez-Aya LF; Mittendorf EA; Litton JK; Wagner J; Hunt KK; Woodward WA; Meric-Bernstam F
    Ann Surg Oncol; 2011 Oct; 18(11):3164-73. PubMed ID: 21947595
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.